Table 2.
Baseline characteristics of the test cohort (N = 23).
| Patient characteristics | |
|---|---|
| Male gender, N (%) | 15 (65) |
| Age, years | 55 ± 16 |
| Mean heart rate, beats/min | 62 ± 9 |
| Mean body mass index, kg/m2 | 25 ± 4 |
| CMR diagnosis | |
| Ischemic cardiomyopathy, N (%) | 8 (35) |
| Non-ischemic cardiomyopathies, N (%) | 15 (65) |
| Dilated cardiomyopathy, N (%) | 3 (13) |
| Myocarditis, N (%) | 8 (35) |
| Hypertrophic cardiomyopathy, N (%) | 3 (13) |
| Arrhythmogenic right ventricular cardiomyopathy, N (%) | 1 (4) |
| Negative CMR, N (%) | 0 (0) |
| Cardiac function | |
| LVEF, %, mean ± SD | 48.2 ± 16.9 |
| Reduced LVEF, N (%) | 13 (57) |
| LV EDV / BSA, mL/m2, mean ± SD | 109.4 ± 34.6 |
| LV ESV / BSA, mL/m2, mean ± SD | 58.2 ± 31.5 |
Note: Data are expressed as mean ± standard deviation unless otherwise specified. Abbreviations: LVEF, left ventricular ejection fraction; EDV, end-diastolic volume; BSA, body surface area; ESV end-systolic volume; LGE late gadolinium enhancement.